Abingworth Management Ltd. Closes 300 Million Stg Life Sciences Fund

January 29, 2007 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

LONDON (AFX) - Biomedical venture capital specialist Abingworth said it has closed its 300 mln stg life sciences fund, Abingworth Bioventures V LP, which will invest in biotechnology and medical companies in Europe and the US.

Twitter
LinkedIn
Facebook
Email
Print

Startups Europe